A US Non-interventional, Effectiveness and Safety Study of Patients Treated With SKYTROFA

Recruiting now

Conditions studied: Growth Hormone Deficiency

In brief

The goal of this study is to genrate evidence on long-term effectiveness and safety of SKYTROFA (lonapegsomatropin) in patients with growth hormone deficiency under routine clinical care

Key facts

Study ID

NCT05820672

Run by

Ascendis Pharma Endocrinology Division A/S

People needed

900

Starts

2023-03-20

Expected to finish

2033-03-01

Last updated by the study team

2026-04-21

Who can join

Age: any. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients who are on treatment with SKYTROFA (lonapegsomatropin)
• Patients being clinically managed in USA
• Patients with an appropriate written informed consent/assent as applicable for the age of the patient

You may not qualify if…

• Patients participating in any interventional clinical study

Where it is running

• Ascendis Investigational Site — Phoenix, Arizona, United States (enrolling)
• Ascendis Investigational Site — Orange, California, United States (enrolling)
• Ascendis Investigational Site — Sacramento, California, United States (enrolling)
• Ascendis Investigational Site — San Francisco, California, United States (enrolling)
• Ascendis Pharma Investigational Site — Centennial, Colorado, United States (enrolling)
• Ascendis Investigational Site — Washington D.C., District of Columbia, United States (enrolling)
• Ascendis Investigational Site — Orlando, Florida, United States (enrolling)
• Ascendis Investigational Site — Orlando, Florida, United States (enrolling)
• Ascendis Investigational Site — Tampa, Florida, United States (enrolling)
• Ascendis Investigational Site — Sandy Springs, Georgia, United States (enrolling)
• Ascendis Investigational Site — Boise, Idaho, United States (enrolling)
• Ascendis Investigational Site — Indianapolis, Indiana, United States (enrolling)
• Ascendis Investigational Site — Iowa City, Iowa, United States (enrolling)
• Ascendis Investigational Site — Louisville, Kentucky, United States (enrolling)
• Ascendis Investigational Site — Minneapolis, Minnesota, United States (enrolling)
• Ascendis Investigational Site — Las Vegas, Nevada, United States (enrolling)
• Ascendis Investigational Site — Lebanon, New Hampshire, United States (enrolling)
• Ascendis Investigational Site — Manchester, New Hampshire, United States (enrolling)
• Ascendis Investigational Site — Morristown, New Jersey, United States (enrolling)
• Ascendis Investigational Site — New Hyde Park, New York, United States (enrolling)
• Ascendis Investigational Site — Cincinnati, Ohio, United States (enrolling)
• Ascendis Investigational Site — Portland, Oregon, United States (enrolling)
• Ascendis Investigational Site — Columbia, South Carolina, United States (enrolling)
• Ascendis Investigational Site — Dallas, Texas, United States (enrolling)
• Ascendis Investigational Site — El Paso, Texas, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.